| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.14B | 14.22B | 13.58B | 12.34B | 11.69B | 10.87B |
| Gross Profit | 5.15B | 10.62B | 10.07B | 9.21B | 8.78B | 8.27B |
| EBITDA | 9.64B | -6.66B | 1.40B | 17.98B | 9.15B | 8.32B |
| Net Income | -6.79B | -8.86B | -1.98B | 15.45B | 6.89B | 1.19B |
Balance Sheet | ||||||
| Total Assets | 225.98B | 229.18B | 252.31B | 268.16B | 225.90B | 210.06B |
| Cash, Cash Equivalents and Short-Term Investments | 3.14B | 3.23B | 9.68B | 17.89B | 2.95B | 2.53B |
| Total Debt | 54.53B | 52.93B | 59.29B | 69.10B | 53.61B | 42.48B |
| Total Liabilities | 67.86B | 65.78B | 73.87B | 79.10B | 62.91B | 51.37B |
| Stockholders Equity | 158.31B | 163.47B | 178.82B | 188.94B | 162.69B | 158.72B |
Cash Flow | ||||||
| Free Cash Flow | 8.21B | 8.94B | 8.40B | -11.17B | -3.20B | -478.00M |
| Operating Cash Flow | 8.23B | 9.01B | 8.48B | 6.27B | 5.84B | 6.29B |
| Investing Cash Flow | 521.00M | 1.52B | -509.00M | -24.69B | -10.70B | -10.68B |
| Financing Cash Flow | -8.09B | -14.36B | -14.71B | 29.85B | 5.12B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $143.40B | 23.78 | 1.89% | 6.20% | -19.91% | -6.92% | |
70 Outperform | HK$147.34B | 12.97 | 2.92% | 4.33% | 9.72% | -26.47% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | HK$10.08B | -8.79 | -4.25% | 7.24% | -4.20% | -138.86% | |
60 Neutral | HK$72.14B | -155.70 | -0.25% | 5.04% | -3.87% | -124.27% | |
55 Neutral | HK$90.58B | -13.16 | -4.11% | 7.61% | -1.84% | -194.03% | |
55 Neutral | HK$14.30B | -5.40 | -6.12% | 5.43% | -6.99% | -176.18% |